Atlas Trials

Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients

Clinical trial NCT04113187 · TERMINATED

Trial details

NCT number
NCT04113187
Sponsor
University Hospital, Bordeaux
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hereditary Hemorrhagic TelangiectasiaOsler Weber Rendu Disease
Start date
2020-06-23
Primary completion
2022-05-19
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.